India SRF buys DuPont's Dymel business and plans pharma plant
India SRF will set up a pharma-grade inhaler propellant manufacturing plant in India with tech and knowhow acquired from US chemical company DuPont.
India SRF will set up a pharma-grade inhaler propellant manufacturing plant in India with tech and knowhow acquired from US chemical company DuPont.
Mobile software modelled on the dating app Tinder could help life science investors find new partners according to networking firm PostHealthcare.
Sartorius AG has announced plans to sell its industrial weighing and control tech business, Intec, as part of a long-term strategy to focus on bioprocessing and laboratory equipment.
Abbvie’s multi-ingredient HCV treatment has been approved in the US, and following an exclusive deal with Express Scripts, could lead to a pricing war with Gilead.
PPD and SNBL will set up a clinical services joint venture (JV) in Japan and collaborate on preclinical and Phase I bridging studies under a new agreement.
The US FDA will give drugmakers and distributors until May to comply with new track and trace laws in order to minimise disruptions in the supply chain.
Injectable-heavy drug pipelines and increased biotech funding are driving up US demand for sterile manufacturing, according to UK-based Symbiosis, which is looking to help fill the gap left by several high-profile exits from the space.